Nakagawa-Saito, Y.; Mitobe, Y.; Togashi, K.; Suzuki, S.; Sugai, A.; Takenouchi, S.; Nakamura, K.; Sonoda, Y.; Kitanaka, C.; Okada, M.
The MDM2–p53 Axis Represents a Therapeutic Vulnerability Unique to Glioma Stem Cells. Int. J. Mol. Sci. 2024, 25, 3948.
https://doi.org/10.3390/ijms25073948
AMA Style
Nakagawa-Saito Y, Mitobe Y, Togashi K, Suzuki S, Sugai A, Takenouchi S, Nakamura K, Sonoda Y, Kitanaka C, Okada M.
The MDM2–p53 Axis Represents a Therapeutic Vulnerability Unique to Glioma Stem Cells. International Journal of Molecular Sciences. 2024; 25(7):3948.
https://doi.org/10.3390/ijms25073948
Chicago/Turabian Style
Nakagawa-Saito, Yurika, Yuta Mitobe, Keita Togashi, Shuhei Suzuki, Asuka Sugai, Senri Takenouchi, Kazuki Nakamura, Yukihiko Sonoda, Chifumi Kitanaka, and Masashi Okada.
2024. "The MDM2–p53 Axis Represents a Therapeutic Vulnerability Unique to Glioma Stem Cells" International Journal of Molecular Sciences 25, no. 7: 3948.
https://doi.org/10.3390/ijms25073948
APA Style
Nakagawa-Saito, Y., Mitobe, Y., Togashi, K., Suzuki, S., Sugai, A., Takenouchi, S., Nakamura, K., Sonoda, Y., Kitanaka, C., & Okada, M.
(2024). The MDM2–p53 Axis Represents a Therapeutic Vulnerability Unique to Glioma Stem Cells. International Journal of Molecular Sciences, 25(7), 3948.
https://doi.org/10.3390/ijms25073948
